Association Recherche biomédicale et Diagnostic
0416.287.871 · rovalta.com · 26/09/2026
ACTIVE
Association Recherche biomédicale et Diagnostic
Financial year 2025 · Closed on 31/12/2025
Net result651,2 k €+12,3 %over 1 year
Gross margin-12,4 k €+94,7 %over 1 year
Equity3,7 M €+21,6 %over 1 year
Overview
Identity
Source · BCE/KBOAssociation Recherche biomédicale et Diagnostic is a Non-profit organization incorporated in 1976. Its registered office is in Woluwe-Saint-Lambert.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0416.287.871
- Incorporation
- 05/05/1976
- Legal form
- Non-profit organization
- Registered office
- Avenue de Juillet 8
1200 Woluwe-Saint-Lambert · BruxellesSee on map - Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflow
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -12,4 k € | +94.7% | -234,1 k € | +25.9% | -316 k € | -7.8% | -293,2 k € | -210% | -94,6 k € |
| EBITDA | -29 k € | +88.3% | -246,8 k € | +23.5% | -322,6 k € | -7.0% | -301,6 k € | -189% | -104,5 k € |
| Operating result | -102,7 k € | +61.2% | -264,3 k € | +22.5% | -341,1 k € | -6.8% | -319,5 k € | -190% | -110,3 k € |
| Net result | 651,2 k € | +12.3% | 580,1 k € | +301% | -288,2 k € | +34.4% | -439,6 k € | -2678% | 17,1 k € |
| Balance sheet | |||||||||
| Equity | 3,7 M € | +21.6% | 3 M € | +23.8% | 2,4 M € | -10.6% | 2,7 M € | -13.9% | 3,2 M € |
| Total assets | 3,7 M € | +21.6% | 3 M € | +23.7% | 2,4 M € | -10.5% | 2,7 M € | -13.9% | 3,2 M € |
| Cash | 1,1 M € | +55.7% | 676,6 k € | +1191% | 52,4 k € | +64.8% | 31,8 k € | -81.7% | 173,6 k € |
| Debts | 520,6 € | -7.2% | 560,8 € | -56.4% | 1,3 k € | +129% | 560,8 € | -61.8% | 1,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20255 active · 6 ended
Active mandates
Christophe Erneux
ActiveGilbert Vassart
ActiveMarc Parmentier
ActiveSabine Costaglioia
ActiveGilbert Vassart
ActiveEnded mandates
SABINE COSTAGLIOLA
EndedSABINE COSTAGLIOLA
EndedGILBERT VASSART
EndedJACQUES DUMONT
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 01/07/2025 | 10/07/2024 | 14/09/2023 | 01/07/2022 | 10/06/2021 |
| General meeting | 19/06/2026 | 06/06/2025 | 21/06/2024 | 02/06/2023 | 28/06/2022 | 09/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 19/06/2026 | 29/06/2026 | French | |
| Abridged model | 31/12/2024 | 06/06/2025 | 01/07/2025 | French | |
| Abridged model | 31/12/2023 | 21/06/2024 | 10/07/2024 | French | |
| Abridged model | 31/12/2022 | 02/06/2023 | 14/09/2023 | French | |
| Abridged model | 31/12/2021 | 28/06/2022 | 01/07/2022 | French | |
| Micro model | 31/12/2020 | 09/06/2021 | 10/06/2021 | French | |
| Abridged model | 31/12/2019 | 05/06/2020 | 29/06/2020 | French | |
| Abridged model | 31/12/2018 | 06/06/2019 | 09/07/2019 | French | |
| Abridged model | 31/12/2017 | 15/06/2018 | 07/09/2018 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20255 active · 6 ended
Active mandates
Christophe Erneux
ActiveGilbert Vassart
ActiveMarc Parmentier
ActiveSabine Costaglioia
ActiveGilbert Vassart
ActiveEnded mandates
SABINE COSTAGLIOLA
EndedSABINE COSTAGLIOLA
EndedGILBERT VASSART
EndedJACQUES DUMONT
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates10/11/2023SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates14/10/2020DEMISSIONS, NOMINATIONS
- Mandates11/09/2018DEMISSIONS, NOMINATIONS
- Mandates10/12/2012DEMISSIONS, NOMINATIONS
- Mandates01/12/2005STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025651,2 k €↑
- 2024Annual accounts 2024580,1 k €↑
- 2023Annual accounts 2023-288,2 k €↑
- 2023Name changeARBD
- 2022Annual accounts 2022-439,6 k €↓
- 2021Annual accounts 202117,1 k €↑
- 2021Name changeA.R.B.D.
- 2020Annual accounts 2020103,9 €↓
- 2019Annual accounts 2019205 k €↑
- 2018Annual accounts 201878,5 k €↓
- 2017Annual accounts 20171,5 M €
- 2017Name changeAssociation Recherche biomédicale et Diagnostic
- 05/05/1976IncorporationNon-profit organization